Dawn Shotland
Senior Vice President, Investment Relations and Corporate Affairs
Replay available
Geron Corporation (NASDAQ: GERN) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Senior Vice President, Investment Relations and Corporate Affairs
Chief Executive Officer
Chief Commercial Officer
Chief Financial Officer
Analyst, TD Cowen
Analyst, Neenah & Company
Analyst, Goldman Sachs
Analyst, H.C. Wainwright & Co.
Analyst, Stifel
Hello, and welcome to General Arm Corporation first quarter 2026 earnings call. At this time, all participants are on listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message as your hand is raised. To withdraw your question, please press star 1-1 again. Please revise that today's conference is pre-recorded. And I turn the call over to Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, Investment Relations and Corporate Affairs. You may begin. Dawn Shotland, Senior Vice President, including those relating to our 2026 financial guidance, our current Britello commercialization strategy, and related opportunities in the U.S. and the EU. The therapeutic potential of ...